Vitestro

#TeamUpdate We're excited to introduce yet another new team member who joined us just last month – Rene van Maarschalkerweerd! With 30 years of experience in the field of financial administration, we are proud to add Rene to our Finance team in this phase of exponential growth! Join us in giving Rene a warm welcome! #BloodDrawPioneers #BloodDraw #Phlebotomy #MedTech #Innovation #NewHire #Career #News #NewTeamMemberAlert #Vitestro

Thank you Helena! [English] What is it like to have blood drawn by a machine? Nearly 200 volunteers tried it out at Amsterdam UMC as part of the A.D.O.P.T. study. This study will teach us a lot about the technical and clinical performance of the autonomous blood-drawing device developed by Vitestro. Such curiosity and enthusiasm for this innovation! Many thanks for the wonderful collaboration over the past 4 weeks! #Vitestro #Bloedafname #MedTech

#TeamUpdate We’re excited to welcome Karin Dijkstra to the Vitestro team! She joined our Mechatronics & Industrialization team as our new Mechanical Engineer. With 15 years of experience in developing diverse products, from medical devices to aviation technology. Karin is even specialized in building fixed-wing drones. We trust Karin to help Vitestro in all aspects of the design, engineering and testing of our amazing blood drawing device. #BloodDrawPioneers #BloodDraw #Phlebotomy #MedTech #Innovation #Career #Vitestro

A.D.O.P.T. Trial Results @ Worldlab It’s been a great couple of days for the Vitestro team at IFCC WorldLab 2024, where we publicly shared results from the A.D.O.P.T. trial. We are proud to report that all performance and safety endpoints were met in the A.D.O.P.T. Pivotal Trial phase. Other key findings include a 95% first-stick success rate and 98% patient acceptance. In the words of Thijs Van Holten, one of the study's Principal Investigators, “These results clearly demonstrate the potential for this new way of managing blood draws using advanced technologies.” The A.D.O.P.T. trial (NCT05878483) is scheduled to run through 2025 and involves 10,000 patients over five study phases. It is the largest evaluation of autonomous blood drawing devices in the world. Thank you to our study partners, St. Antonius Ziekenhuis, OLVG Lab BV, Result Laboratorium, and Amsterdam UMC for the great collaboration. We look forward to continuing the A.D.O.P.T. trial! Please check out the link below to see more details and to download the study results. https://lnkd.in/eGyhWwjE

A.D.O.P.T. Trial Results @ Worldlab It’s been a great couple of days for the Vitestro team at IFCC WorldLab 2024, where we publicly shared results from the A.D.O.P.T. trial. We are proud to report that all performance and safety endpoints were met in the A.D.O.P.T. Pivotal Trial phase. Other key findings include a 95% first-stick success rate and 98% patient acceptance. In the words of Thijs Van Holten, one of the study's Principal Investigators, “These results clearly demonstrate the potential for this new way of managing blood draws using advanced technologies.” The A.D.O.P.T. trial (NCT05878483) is scheduled to run through 2025 and involves 10,000 patients over five study phases. It is the largest evaluation of autonomous blood drawing devices in the world. Thank you to our study partners, St. Antonius Ziekenhuis, OLVG Lab BV, Result Laboratorium, and Amsterdam UMC for the great collaboration. We look forward to continuing the A.D.O.P.T. trial! Please check out the link below to see more details and to download the study results. https://lnkd.in/eGyhWwjE

🔎 Voor Vitestro ben ik op zoek naar een JUNIOR COMMERCIAL OPERATIONS MANAGER In deze rol ga je > Ondersteunen bij sales-activiteiten en business development dmv het maken van sales-pitches en overtuigende businesscases. > Onze commerciële afdeling helpen bij het opstellen en verfijnen van workflows. > Rapportages maken over de operationele voortgang ter ondersteuning van strategische besluitvorming. 👣 Deze rol zou goed passen bij iemand die toe is aan de tweede stap. Iemand met een paar jaar ervaring als associate bij een consultancy firm of als inside sales bij een commerciële partij. 📊 Het is een spannende rol voor iemand die houdt van cijfers en data analyse en van het maken van strakke presentaties. Je gaat werken met onze strateeg en de VP Sales & Marketing Europe. 💉 Vitestro gaat de wereld van de zorg ingrijpend veranderen met de ontwikkeling van een volledig autonome bloedafname-robot en heeft de documenten ter goedkeuring bij de FDA en EMA ingediend. Daarnaast is er onlangs $20mio in het bedrijf geïnvesteerd. Een spannende en opwindende tijd en een mooi moment om je bij ons aan te sluiten! 💰Wij bieden een ambitieuze en getalenteerde werkomgeving waar belang wordt gehecht aan jouw persoonlijke ontwikkeling en groei. Daarom is er een flink budget voor jouw zelfontplooiing. Natuurlijk word je goed beloond en is equity een deel van je pakket. 🔘 Solliciteren kan snel via de button in de job. Niet voor jou? Voel je vrij om deze post te delen. #sales #salesoperations #businessdevelopment #juniorsales

As if the month of May wasn’t exciting enough… We’re proud to share: In a first international pre-order for Vitestro, the Danish Odense University Hospital pre-orders 3 blood drawing devices. This exciting collaboration coming from Odense (labelled ‘the world’s best robot city’) is showing a global need for the Vitestro solution. For our Danish connections: Going to the Hospital Automation Summit in Odense this week (Odense Robotics)? Join Wessel van Dijk presenting the future of phlebotomy at the summit and come see us at our booth! Read more at: https://lnkd.in/evv8ZuaK #Vitestro #Odense #Phlebotomy #Innovation

As special guest at Lucien Engelen's keynote speech at ICT&health, Toon Overbeeke had a surprise for the audience as he shared his vision for the future of autonomous phlebotomy: 💡 For the first time ever a demonstration of the Vitestro device was given live on stage, featuring our vein finding technology! Other exciting keynotes were given by John Halamka, M.D., M.S. (Mayo Clinic), Helen Mertens (Maastricht UMC) and Bianca Rouwenhorst (Dutch Ministry of Health). Stay tuned for more exciting news in the coming weeks! #Vitestro #ICTHealth #Phlebotomy #Maastricht

As special guest at Lucien Engelen's keynote speech at ICT&health, Toon Overbeeke had a surprise for the audience as he shared his vision for the future of autonomous phlebotomy: 💡 For the first time ever a demonstration of the Vitestro device was given live on stage, featuring our vein finding technology! Other exciting keynotes were given by John Halamka, M.D., M.S. (Mayo Clinic), Helen Mertens (Maastricht UMC) and Bianca Rouwenhorst (Dutch Ministry of Health). Stay tuned for more exciting news in the coming weeks! #Vitestro #ICTHealth #Phlebotomy #Maastricht

📢Breaking News from the Vitestro team! We're excited to share news of a $22 million (€20 million) funding round completion - a big milestone for the company and validation of its anticipated transformation of the healthcare sector. With this support, we can accelerate the commercialization of Vitestro's autonomous blood drawing device and expand our team to meet growing demand in Europe and the USA. Our technology is poised to transform what is one of the oldest and most common invasive procedures in all of medicine. Toon Overbeeke, CEO and co-founder: "I'm so proud of the Vitestro team, their dedication and hard work led to this strong endorsement and is setting us up for success in the coming years. We're also very grateful for the ongoing support from Sonder and existing private investors, and want to take a moment to welcome the new investors to the Vitestro team". The oversubscribed funding round was co-led by return investor Sonder Capital, with new investor NYBC Ventures, and participation from Invest-NL, European Investment Council Fund (European Innovation Council and SMEs Executive Agency (EISMEA)) and existing private investors. 🔗Read more (English): https://hubs.la/Q02vsJzf0 🔗Read more (Nederlands): https://hubs.la/Q02vsDTC0 In the photo: * Dr. Fred Moll (left), managing partner at Sonder Capital and co-founder of Intuitive Surgical, the company behind the da Vinci robot. * Toon Overbeeke (right), CEO and co-founder at Vitestro #Vitestro #BloodDrawDevice #MedTech #Funding